Insulet (PODD) Directors and Executive Officers

Officers & Directors

Elizabeth Weatherman
Director

James R. Hollingshead
Chief Executive Officer (Principal Executive Officer)

Luciana Borio, M.D.
Director

Lauren D. Budden
Interim Chief Financial Officer, Group Vice President, Chief Accounting Officer and Controller (Principal Financial and Accounting Officer)

Wayne A.I. Frederick, M.D.
Director

Jessica Hopfield
Director

Timothy J. Scannell
Director

Timothy C. Stonesifer
Director

Michael R. Minogue
Director

Corinne H. Nevinny
Director

Flavia H. Pease
Director

Shacey Petrovic
Director

Grant Thornton LLP
Boston, Massachusetts - Auditor for the Company.,

Insulet Corporation currently has 5400 employees.

News about Insulet Corporation Key Personnel

Insulet Corporation Appoints Ana Maria Chadwick as CFO, Marking a New Milestone in Financial Leadership

ACTON, Mass. - In a strategic move to strengthen its financial leadership, the global leader in tubeless insulin pump technology, Insulet Corporation (NASDAQ: PODD), has announced the appointment of Ana Maria Chadwick as Executive Vice President, Chief Financial Officer (CFO), and Treasurer. Chadwick will assume her new role effective April 22, 2024, signaling an exciting new chapter for the company.
The selection of Chadwick as CFO comes after an extensive search process conducted by Insulet Corporation, which sought an individual who could contribute to maintaining and expanding the company s success. With her extensive financial expertise and strategic insights, Chadwick is poised to play a pivot...

Insulet Corporation Strengthened with New Board Appointments and Retirements, Aims to Steer Financial Stability and Drive Growth

Insulet Announces Changes to Board of Directors with Retirements and New Appointments
ACTON, Mass. - Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology with its Omnipod brand of products, is proud to announce significant changes to its Board of Directors. These changes, effective January 18, reflect the company s commitment to expert guidance and strategic leadership as it continues to revolutionize the healthcare industry.
Joining the esteemed board are Flavia Pease, Corporate Executive Vice President and Chief Financial Officer at Charles River Laboratories, and Timothy Stonesifer, Chief Financial Officer at Alcon Inc. Both industry leaders bring a wealth of e...